SPATA13
Basic information
Region (hg38): 13:23979804-24307074
Links
Phenotypes
GenCC
Source:
- primary angle-closure glaucoma (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (56 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPATA13 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 52 | 56 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 0 | |||||
non coding ? | 0 | |||||
Total | 0 | 0 | 52 | 5 | 0 |
Variants in SPATA13
This is a list of pathogenic ClinVar variants found in the SPATA13 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-24222869-C-T | SPATA13-related disorder | Benign (Aug 22, 2019) | ||
13-24222937-A-G | not specified | Uncertain significance (Dec 05, 2022) | ||
13-24222945-G-A | not specified | Uncertain significance (May 03, 2023) | ||
13-24222949-G-A | not specified | Uncertain significance (Jan 19, 2022) | ||
13-24222973-A-G | not specified | Uncertain significance (Jun 24, 2022) | ||
13-24222973-A-T | not specified | Uncertain significance (May 09, 2023) | ||
13-24222999-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
13-24223015-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
13-24223031-G-A | SPATA13-related disorder | Likely benign (Feb 22, 2019) | ||
13-24223053-G-A | not specified | Uncertain significance (Aug 09, 2021) | ||
13-24223062-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
13-24223080-G-A | not specified | Uncertain significance (Jun 06, 2023) | ||
13-24223103-C-T | SPATA13-related disorder | Likely benign (May 24, 2019) | ||
13-24223120-A-T | not specified | Uncertain significance (Oct 26, 2021) | ||
13-24223147-T-C | not specified | Uncertain significance (Sep 07, 2022) | ||
13-24223195-G-C | SPATA13-related disorder | Benign (Aug 12, 2019) | ||
13-24223312-G-A | not specified | Uncertain significance (Mar 07, 2024) | ||
13-24223324-A-T | not specified | Uncertain significance (Sep 07, 2022) | ||
13-24223347-T-G | not specified | Uncertain significance (Oct 26, 2021) | ||
13-24223348-C-T | not specified | Likely benign (Jul 28, 2021) | ||
13-24223425-C-G | not specified | Uncertain significance (May 11, 2022) | ||
13-24223426-C-T | SPATA13-related disorder | Likely benign (Oct 10, 2022) | ||
13-24223429-G-T | not specified | Uncertain significance (Oct 05, 2023) | ||
13-24223452-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
13-24223508-C-A | not specified | Uncertain significance (Mar 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SPATA13 | protein_coding | protein_coding | ENST00000424834 | 12 | 327269 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00264 | 0.997 | 125720 | 0 | 28 | 125748 | 0.000111 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.03 | 636 | 797 | 0.798 | 0.0000500 | 8391 |
Missense in Polyphen | 147 | 248.91 | 0.59057 | 2629 | ||
Synonymous | 1.78 | 288 | 329 | 0.875 | 0.0000217 | 2551 |
Loss of Function | 4.50 | 14 | 47.4 | 0.295 | 0.00000235 | 552 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.000298 | 0.000298 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000140 | 0.000139 |
European (Non-Finnish) | 0.000162 | 0.000158 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as guanine nucleotide exchange factor (GEF) for RHOA, RAC1 and CDC42 GTPases. Regulates cell migration and adhesion assembly and disassembly through a RAC1, PI3K, RHOA and AKT1-dependent mechanism. Increases both RAC1 and CDC42 activity, but decreases the amount of active RHOA. Required for MMP9 up- regulation via the JNK signaling pathway in colorectal tumor cells. Involved in tumor angiogenesis and may play a role in intestinal adenoma formation and tumor progression. {ECO:0000269|PubMed:17145773, ECO:0000269|PubMed:17599059, ECO:0000269|PubMed:19151759, ECO:0000269|PubMed:19893577, ECO:0000269|PubMed:19934221}.;
- Pathway
- Regulation of actin cytoskeleton - Homo sapiens (human);Regulation of RAC1 activity;Regulation of CDC42 activity
(Consensus)
Recessive Scores
- pRec
- 0.112
Intolerance Scores
- loftool
- 0.257
- rvis_EVS
- 2.01
- rvis_percentile_EVS
- 97.67
Haploinsufficiency Scores
- pHI
- 0.287
- hipred
- N
- hipred_score
- 0.259
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.214
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Spata13
- Phenotype
- homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm; digestive/alimentary phenotype;
Gene ontology
- Biological process
- cell migration;lamellipodium assembly;regulation of cell migration;regulation of Rho protein signal transduction;filopodium assembly
- Cellular component
- nucleoplasm;cytoplasm;cytosol;lamellipodium;filopodium;ruffle membrane
- Molecular function
- guanyl-nucleotide exchange factor activity;protein binding;Rac guanyl-nucleotide exchange factor activity